SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001104659-13-003831
Filing Date
2013-01-22
Accepted
2013-01-22 16:18:38
Documents
3

Document Format Files

Seq Description Document Type Size
1 425 a12-25351_9425.htm 425 36039
2 GRAPHIC g253519bci001.jpg GRAPHIC 5630
3 GRAPHIC g253519bci002.jpg GRAPHIC 5021
  Complete submission text file 0001104659-13-003831.txt   52755
Mailing Address 111 BARCLAY BLVD LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Filed by) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 111 BARCLAY BLVD LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Subject) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-31812 | Film No.: 13540540
SIC: 2836 Biological Products, (No Diagnostic Substances)